AstraZeneca vaccine

Canada is about to toss more than half of its doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.

Canada's envoy to the United Nations says Canada needs to share more of its COVID-19 vaccine surpluses with less fortunate countries.

Further deliveries of COVID-19 vaccines to Canada are on pause because provinces already have more doses than they can currently use.

It's pronounced koh-MIHR'-nuh-tee. Never heard of it? Well, get used to it. It's what Canada will be calling the Pfizer vaccine from now on, at least officially.

Canada is donating all 10 million doses of the single-dose vaccine that it purchased from Johnson & Johnson but won't use to low and middle-income countries.

In the debate over COVID-19 vaccine patents, a flawed logic is being used to justify putting profits above saving lives.

The federal government is expecting to receive about 7.1 million doses of COVID-19 vaccines this week, as it adjusts its distribution strategy amid waning vaccination rates and substantial supply.

How a team of physicians, nurses, and volunteers undertook a three-week journey to vaccinate land protectors in Brazil's rainforests.

A vaccine study in the United Kingdom reports that getting a dose of the Pfizer-BioNTech vaccine four weeks after a dose of Oxford-AstraZeneca produced a much stronger immune response than two doses of AstraZeneca.

Officials and experts emphasized the interchangeability of the Moderna and Pfizer-BioNTech vaccines on Monday as shipment delays led to changes in Canadians' second-dose appointments.  

Canadians fully immunized with two shots of the Oxford-AstraZeneca COVID-19 vaccine may now attend a highly anticipated Broadway production featuring Bruce Springsteen, but at least one Canadian hoping to take in the show still has questions about whether or not he can attend.

The latest recommendation from NACI has Canadians who chose AstraZeneca for both doses wondering if they did the right thing.

A new study in England suggests even just one dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines are extremely good at keeping people from ending up in the hospital if they contract COVID-19 from the Delta variant of the virus that causes it.

Impatience and a lack of clarity persisted Thursday over the fate of thousands of doses of the Oxford-AstraZeneca vaccine set to expire in the coming weeks.